nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ABCB1—Topotecan—cervical cancer	0.248	0.625	CbGbCtD
Naloxone—CYP3A4—Topotecan—cervical cancer	0.149	0.375	CbGbCtD
Naloxone—CREB1—exocrine gland—cervical cancer	0.0243	0.0887	CbGeAlD
Naloxone—TLR4—decidua—cervical cancer	0.0227	0.0828	CbGeAlD
Naloxone—TLR4—endometrium—cervical cancer	0.0215	0.0786	CbGeAlD
Naloxone—TLR4—female gonad—cervical cancer	0.0162	0.0592	CbGeAlD
Naloxone—CREB1—epithelium—cervical cancer	0.0106	0.0386	CbGeAlD
Naloxone—CREB1—uterine cervix—cervical cancer	0.0105	0.0383	CbGeAlD
Naloxone—TLR4—lymph node—cervical cancer	0.0104	0.0381	CbGeAlD
Naloxone—CREB1—decidua—cervical cancer	0.00998	0.0364	CbGeAlD
Naloxone—CREB1—renal system—cervical cancer	0.0098	0.0358	CbGeAlD
Naloxone—CREB1—endometrium—cervical cancer	0.00948	0.0346	CbGeAlD
Naloxone—CREB1—mammalian vulva—cervical cancer	0.00917	0.0335	CbGeAlD
Naloxone—CREB1—uterus—cervical cancer	0.00873	0.0319	CbGeAlD
Naloxone—CREB1—female reproductive system—cervical cancer	0.00785	0.0287	CbGeAlD
Naloxone—OPRD1—renal system—cervical cancer	0.00775	0.0283	CbGeAlD
Naloxone—CREB1—female gonad—cervical cancer	0.00714	0.0261	CbGeAlD
Naloxone—CREB1—vagina—cervical cancer	0.0071	0.0259	CbGeAlD
Naloxone—OPRK1—female reproductive system—cervical cancer	0.00595	0.0217	CbGeAlD
Naloxone—CREB1—lymph node—cervical cancer	0.00459	0.0168	CbGeAlD
Naloxone—SLCO1A2—renal system—cervical cancer	0.00455	0.0166	CbGeAlD
Naloxone—ESR1—epithelium—cervical cancer	0.00416	0.0152	CbGeAlD
Naloxone—ESR1—uterine cervix—cervical cancer	0.00413	0.0151	CbGeAlD
Naloxone—ESR1—decidua—cervical cancer	0.00393	0.0143	CbGeAlD
Naloxone—ESR1—renal system—cervical cancer	0.00386	0.0141	CbGeAlD
Naloxone—ESR1—endometrium—cervical cancer	0.00373	0.0136	CbGeAlD
Naloxone—ESR1—uterus—cervical cancer	0.00344	0.0126	CbGeAlD
Naloxone—CYP2C8—renal system—cervical cancer	0.00318	0.0116	CbGeAlD
Naloxone—ESR1—female reproductive system—cervical cancer	0.00309	0.0113	CbGeAlD
Naloxone—CYP2C8—endometrium—cervical cancer	0.00307	0.0112	CbGeAlD
Naloxone—ESR1—female gonad—cervical cancer	0.00281	0.0103	CbGeAlD
Naloxone—ESR1—vagina—cervical cancer	0.0028	0.0102	CbGeAlD
Naloxone—CYP2C8—female reproductive system—cervical cancer	0.00255	0.00929	CbGeAlD
Naloxone—CYP2C8—vagina—cervical cancer	0.0023	0.00841	CbGeAlD
Naloxone—CYP3A4—renal system—cervical cancer	0.00215	0.00786	CbGeAlD
Naloxone—ALB—lymph node—cervical cancer	0.00212	0.00774	CbGeAlD
Naloxone—ESR1—lymph node—cervical cancer	0.00181	0.0066	CbGeAlD
Naloxone—CYP3A4—female reproductive system—cervical cancer	0.00172	0.0063	CbGeAlD
Naloxone—ABCB1—epithelium—cervical cancer	0.00164	0.006	CbGeAlD
Naloxone—ABCB1—uterine cervix—cervical cancer	0.00163	0.00595	CbGeAlD
Naloxone—ABCB1—decidua—cervical cancer	0.00155	0.00567	CbGeAlD
Naloxone—ABCB1—renal system—cervical cancer	0.00152	0.00556	CbGeAlD
Naloxone—ABCB1—endometrium—cervical cancer	0.00147	0.00538	CbGeAlD
Naloxone—ABCB1—mammalian vulva—cervical cancer	0.00143	0.0052	CbGeAlD
Naloxone—ABCB1—uterus—cervical cancer	0.00136	0.00496	CbGeAlD
Naloxone—ABCB1—female reproductive system—cervical cancer	0.00122	0.00446	CbGeAlD
Naloxone—ABCB1—female gonad—cervical cancer	0.00111	0.00405	CbGeAlD
Naloxone—ABCB1—vagina—cervical cancer	0.0011	0.00403	CbGeAlD
Naloxone—ABCB1—lymph node—cervical cancer	0.000714	0.00261	CbGeAlD
Naloxone—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00047	0.00143	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—MTOR—cervical cancer	0.00047	0.00143	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.00047	0.00143	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—MTOR—cervical cancer	0.000468	0.00142	CbGpPWpGaD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—cervical cancer	0.000467	0.00142	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—EGFR—cervical cancer	0.000467	0.00142	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—MTOR—cervical cancer	0.000465	0.00141	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000465	0.00141	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	0.00046	0.0014	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	0.000459	0.00139	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TAAR6—cervical cancer	0.000458	0.00139	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—CTNNB1—cervical cancer	0.000458	0.00139	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000457	0.00139	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000445	0.00135	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000441	0.00134	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—STAT3—cervical cancer	0.00044	0.00134	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—WNT2—cervical cancer	0.00044	0.00133	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—WNT2—cervical cancer	0.000438	0.00133	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—MTOR—cervical cancer	0.000438	0.00133	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—MTOR—cervical cancer	0.000438	0.00133	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.000438	0.00133	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—RARB—cervical cancer	0.000436	0.00132	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—MTOR—cervical cancer	0.000434	0.00132	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—STAT3—cervical cancer	0.000433	0.00131	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—EGFR—cervical cancer	0.000433	0.00131	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CTNNB1—cervical cancer	0.000432	0.00131	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.00043	0.0013	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000429	0.0013	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—MTOR—cervical cancer	0.000428	0.0013	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGFR3—cervical cancer	0.000424	0.00129	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.000424	0.00129	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TAAR6—cervical cancer	0.000416	0.00126	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—STAT3—cervical cancer	0.000406	0.00123	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—MTOR—cervical cancer	0.000405	0.00123	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGFR3—cervical cancer	0.000403	0.00122	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—STAT3—cervical cancer	0.000399	0.00121	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000396	0.0012	CbGpPWpGaD
Naloxone—CREB1—Immune System—UBE3A—cervical cancer	0.000396	0.0012	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DPB1—cervical cancer	0.000389	0.00118	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000388	0.00118	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKAP13—cervical cancer	0.000386	0.00117	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKAP13—cervical cancer	0.000385	0.00117	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—WNT2—cervical cancer	0.000384	0.00117	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TP53—cervical cancer	0.000381	0.00115	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000379	0.00115	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKAP13—cervical cancer	0.000371	0.00113	CbGpPWpGaD
Naloxone—CREB1—Disease—WNT2—cervical cancer	0.000371	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—EGFR—cervical cancer	0.000369	0.00112	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000365	0.00111	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—STAT3—cervical cancer	0.000365	0.00111	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000363	0.0011	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—cervical cancer	0.000355	0.00108	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000353	0.00107	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000352	0.00107	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000349	0.00106	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—EGFR—cervical cancer	0.000347	0.00105	CbGpPWpGaD
Naloxone—TLR4—Immune System—CASP8—cervical cancer	0.000345	0.00105	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—EGFR—cervical cancer	0.000342	0.00104	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HES1—cervical cancer	0.00034	0.00103	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—STAT3—cervical cancer	0.000338	0.00103	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKAP13—cervical cancer	0.000337	0.00102	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—WNT5A—cervical cancer	0.000333	0.00101	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TAAR6—cervical cancer	0.000333	0.00101	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—WNT5A—cervical cancer	0.000332	0.00101	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—EGFR—cervical cancer	0.000332	0.00101	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TAAR6—cervical cancer	0.000332	0.00101	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—STAT3—cervical cancer	0.000331	0.001	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—EGFR—cervical cancer	0.00033	0.001	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.00033	0.001	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—EGFR—cervical cancer	0.000328	0.000997	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000328	0.000995	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—EGFR—cervical cancer	0.000327	0.000992	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000326	0.000988	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—WNT2—cervical cancer	0.000325	0.000985	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—MTOR—cervical cancer	0.000324	0.000983	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	0.000322	0.000978	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKAP13—cervical cancer	0.000314	0.000953	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—EGFR—cervical cancer	0.000308	0.000933	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—EGFR—cervical cancer	0.000308	0.000933	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000308	0.000933	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—EGFR—cervical cancer	0.000305	0.000925	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000304	0.000922	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000302	0.000917	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—EGFR—cervical cancer	0.000301	0.000913	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.0003	0.000909	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.0003	0.000909	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—MTOR—cervical cancer	0.000298	0.000905	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000293	0.00089	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—WNT5A—cervical cancer	0.000291	0.000883	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TAAR6—cervical cancer	0.000291	0.000882	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000289	0.000878	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000289	0.000877	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000289	0.000876	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKAP13—cervical cancer	0.000285	0.000865	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—EGFR—cervical cancer	0.000285	0.000864	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD8A—cervical cancer	0.000284	0.000861	CbGpPWpGaD
Naloxone—TLR4—Immune System—MTOR—cervical cancer	0.000284	0.000861	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD4—cervical cancer	0.000283	0.00086	CbGpPWpGaD
Naloxone—CREB1—Disease—WNT5A—cervical cancer	0.000281	0.000853	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—CASP3—cervical cancer	0.000274	0.000832	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000272	0.000826	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CASP3—cervical cancer	0.000266	0.000807	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000263	0.000799	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WNT2—cervical cancer	0.00026	0.000788	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WNT2—cervical cancer	0.000259	0.000785	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NOTCH1—cervical cancer	0.000257	0.00078	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTNNB1—cervical cancer	0.000252	0.000764	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000248	0.000753	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—WNT5A—cervical cancer	0.000246	0.000747	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TAAR6—cervical cancer	0.000246	0.000746	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000243	0.000737	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGFR3—cervical cancer	0.000242	0.000734	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000239	0.000726	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CA9—cervical cancer	0.000237	0.00072	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DPB1—cervical cancer	0.000236	0.000717	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—cervical cancer	0.000233	0.000708	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGFR3—cervical cancer	0.000232	0.000705	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—STAT3—cervical cancer	0.00023	0.000699	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000229	0.000694	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKAP13—cervical cancer	0.000228	0.000692	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—EGFR—cervical cancer	0.000228	0.00069	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKAP13—cervical cancer	0.000227	0.000689	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WNT2—cervical cancer	0.000227	0.000689	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—cervical cancer	0.000225	0.000682	CbGpPWpGaD
Naloxone—TLR4—Immune System—STAT3—cervical cancer	0.000219	0.000666	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TAAR6—cervical cancer	0.000218	0.000661	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—RARB—cervical cancer	0.00021	0.000637	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—EGFR—cervical cancer	0.000209	0.000636	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CASP8—cervical cancer	0.000207	0.000627	CbGpPWpGaD
Naloxone—TLR4—Immune System—EGFR—cervical cancer	0.000199	0.000605	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKAP13—cervical cancer	0.000199	0.000605	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WNT5A—cervical cancer	0.000197	0.000597	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WNT5A—cervical cancer	0.000196	0.000595	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000192	0.000583	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WNT2—cervical cancer	0.000192	0.000582	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—EGFR—cervical cancer	0.00019	0.000575	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.00019	0.000575	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DQB1—cervical cancer	0.000184	0.00056	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000179	0.000543	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000174	0.000527	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD8A—cervical cancer	0.000172	0.000522	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WNT5A—cervical cancer	0.000172	0.000522	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CTNNB1—cervical cancer	0.000171	0.000518	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—MTOR—cervical cancer	0.00017	0.000516	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT2—cervical cancer	0.00017	0.000516	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—cervical cancer	0.00017	0.000515	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKAP13—cervical cancer	0.000168	0.000511	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—MTOR—cervical cancer	0.000163	0.000496	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—cervical cancer	0.000163	0.000495	CbGpPWpGaD
Naloxone—CREB1—Disease—HES1—cervical cancer	0.000162	0.000491	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000159	0.000483	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTNNB1—cervical cancer	0.000151	0.000458	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKAP13—cervical cancer	0.000149	0.000453	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—STAT3—cervical cancer	0.000149	0.000452	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WNT5A—cervical cancer	0.000145	0.000441	CbGpPWpGaD
Naloxone—CREB1—Disease—MTHFR—cervical cancer	0.000142	0.000431	CbGpPWpGaD
Naloxone—CREB1—Disease—TERT—cervical cancer	0.000142	0.00043	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR3—cervical cancer	0.000141	0.000427	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NOTCH2—cervical cancer	0.000139	0.000422	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOTCH2—cervical cancer	0.000138	0.000419	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000138	0.000418	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EGFR—cervical cancer	0.000135	0.000411	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000131	0.000398	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR3—cervical cancer	0.00013	0.000395	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT5A—cervical cancer	0.000129	0.000391	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000127	0.000384	CbGpPWpGaD
Naloxone—CREB1—Disease—NOTCH1—cervical cancer	0.000122	0.00037	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOTCH2—cervical cancer	0.000121	0.000366	CbGpPWpGaD
Naloxone—CREB1—Immune System—CASP8—cervical cancer	0.00012	0.000365	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EGFR—cervical cancer	0.000119	0.000363	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CA9—cervical cancer	0.000117	0.000354	CbGpPWpGaD
Naloxone—ALB—Metabolism—CA9—cervical cancer	0.000116	0.000352	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—EGFR—cervical cancer	0.000115	0.000348	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HES1—cervical cancer	0.000113	0.000344	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HES1—cervical cancer	0.000113	0.000342	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000102	0.00031	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CA9—cervical cancer	0.000102	0.000308	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.0001	0.000304	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TERT—cervical cancer	9.92e-05	0.000301	CbGpPWpGaD
Naloxone—CREB1—Immune System—MTOR—cervical cancer	9.91e-05	0.000301	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HES1—cervical cancer	9.9e-05	0.0003	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TERT—cervical cancer	9.89e-05	0.0003	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—cervical cancer	9.89e-05	0.0003	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MTHFR—cervical cancer	9.63e-05	0.000292	CbGpPWpGaD
Naloxone—CREB1—Disease—MTOR—cervical cancer	9.15e-05	0.000278	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—cervical cancer	9.13e-05	0.000277	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR3—cervical cancer	9.11e-05	0.000276	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR3—cervical cancer	9.08e-05	0.000275	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOTCH2—cervical cancer	9.05e-05	0.000274	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTNNB1—cervical cancer	8.78e-05	0.000267	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TERT—cervical cancer	8.67e-05	0.000263	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NOTCH1—cervical cancer	8.61e-05	0.000261	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOTCH1—cervical cancer	8.55e-05	0.000259	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOTCH1—cervical cancer	8.52e-05	0.000259	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.42e-05	0.000255	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HES1—cervical cancer	8.36e-05	0.000254	CbGpPWpGaD
Naloxone—CREB1—Disease—CTNNB1—cervical cancer	8.11e-05	0.000246	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR3—cervical cancer	7.96e-05	0.000241	CbGpPWpGaD
Naloxone—CREB1—Immune System—STAT3—cervical cancer	7.66e-05	0.000232	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—cervical cancer	7.62e-05	0.000231	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—cervical cancer	7.59e-05	0.00023	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOTCH1—cervical cancer	7.47e-05	0.000227	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HES1—cervical cancer	7.42e-05	0.000225	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TERT—cervical cancer	7.33e-05	0.000222	CbGpPWpGaD
Naloxone—CREB1—Disease—STAT3—cervical cancer	7.07e-05	0.000215	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—cervical cancer	6.96e-05	0.000211	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR3—cervical cancer	6.73e-05	0.000204	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—cervical cancer	6.66e-05	0.000202	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TERT—cervical cancer	6.5e-05	0.000197	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—cervical cancer	6.43e-05	0.000195	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MTOR—cervical cancer	6.41e-05	0.000194	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MTOR—cervical cancer	6.39e-05	0.000194	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOTCH1—cervical cancer	6.32e-05	0.000192	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CA9—cervical cancer	6.26e-05	0.00019	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR3—cervical cancer	5.96e-05	0.000181	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CASP3—cervical cancer	5.89e-05	0.000179	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CASP3—cervical cancer	5.87e-05	0.000178	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CTNNB1—cervical cancer	5.68e-05	0.000172	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CTNNB1—cervical cancer	5.66e-05	0.000172	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—cervical cancer	5.63e-05	0.000171	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOTCH1—cervical cancer	5.6e-05	0.00017	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MTOR—cervical cancer	5.6e-05	0.00017	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CASP3—cervical cancer	5.15e-05	0.000156	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CTNNB1—cervical cancer	4.96e-05	0.000151	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STAT3—cervical cancer	4.95e-05	0.00015	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STAT3—cervical cancer	4.93e-05	0.00015	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTHFR—cervical cancer	4.73e-05	0.000144	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MTOR—cervical cancer	4.73e-05	0.000144	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTHFR—cervical cancer	4.71e-05	0.000143	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—cervical cancer	4.5e-05	0.000137	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—cervical cancer	4.48e-05	0.000136	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—cervical cancer	4.41e-05	0.000134	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CASP3—cervical cancer	4.35e-05	0.000132	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—STAT3—cervical cancer	4.33e-05	0.000131	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MTOR—cervical cancer	4.2e-05	0.000127	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CTNNB1—cervical cancer	4.2e-05	0.000127	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTHFR—cervical cancer	4.12e-05	0.000125	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—cervical cancer	3.93e-05	0.000119	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CASP3—cervical cancer	3.86e-05	0.000117	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—cervical cancer	3.78e-05	0.000115	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—cervical cancer	3.77e-05	0.000114	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CTNNB1—cervical cancer	3.72e-05	0.000113	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STAT3—cervical cancer	3.66e-05	0.000111	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—cervical cancer	3.32e-05	0.000101	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—cervical cancer	3.3e-05	0.0001	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STAT3—cervical cancer	3.24e-05	9.84e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—cervical cancer	2.95e-05	8.94e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—cervical cancer	2.79e-05	8.47e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTHFR—cervical cancer	2.54e-05	7.71e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—cervical cancer	2.47e-05	7.51e-05	CbGpPWpGaD
